LONDON: RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company focusing on high-growth potential assets in the life sciences sector, has announced a new investment in Alesta Therapeutics. The Netherlands-based biotechnology firm, Alesta, is dedicated to developing novel oral small molecule therapies for rare, underserved diseases. Alesta Therapeutics recently completed a €65 million (US$67…